142 related articles for article (PubMed ID: 9800881)
1. Programmed cell death in the progression of heart failure.
Sabbah HN; Sharov VG; Goldstein S
Ann Med; 1998 Aug; 30 Suppl 1():33-8. PubMed ID: 9800881
[TBL] [Abstract][Full Text] [Related]
2. Cell death, tissue hypoxia and the progression of heart failure.
Sabbah HN; Sharov VG; Goldstein S
Heart Fail Rev; 2000 Jun; 5(2):131-8. PubMed ID: 16228140
[TBL] [Abstract][Full Text] [Related]
3. The cellular and physiologic effects of beta blockers in heart failure.
Sabbah HN
Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis in heart failure.
Sabbah HN; Sharov VG
Prog Cardiovasc Dis; 1998; 40(6):549-62. PubMed ID: 9647609
[TBL] [Abstract][Full Text] [Related]
5. [The role of myocardial apoptosis in the development of heart failure].
Andréka P; Müzes G; Nádházi Z
Orv Hetil; 1999 Jan; 140(3):135-42. PubMed ID: 9990818
[TBL] [Abstract][Full Text] [Related]
6. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of disease: apoptosis in heart failure--seeing hope in death.
Narula J; Haider N; Arbustini E; Chandrashekhar Y
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):681-8. PubMed ID: 17122801
[TBL] [Abstract][Full Text] [Related]
8. [Phenotype alterations of failing myocardium].
Takemura G; Fujiwara H
Nihon Rinsho; 2003 May; 61(5):731-8. PubMed ID: 12754995
[TBL] [Abstract][Full Text] [Related]
9. Contribution of non-cardiomyocyte apoptosis to cardiac remodelling that occurs in the transition from compensated hypertrophy to heart failure in spontaneously hypertensive rats.
Ikeda S; Hamada M; Hiwada K
Clin Sci (Lond); 1999 Aug; 97(2):239-46. PubMed ID: 10409480
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation.
van Empel VP; Bertrand AT; van der Nagel R; Kostin S; Doevendans PA; Crijns HJ; de Wit E; Sluiter W; Ackerman SL; De Windt LJ
Circ Res; 2005 Jun; 96(12):e92-e101. PubMed ID: 15933268
[TBL] [Abstract][Full Text] [Related]
11. Myocyte apoptosis in heart failure.
van Empel VP; Bertrand AT; Hofstra L; Crijns HJ; Doevendans PA; De Windt LJ
Cardiovasc Res; 2005 Jul; 67(1):21-9. PubMed ID: 15896727
[TBL] [Abstract][Full Text] [Related]
12. Cytopathological basis of heart failure--cardiomyocyte apoptosis, interstitial fibrosis and inflammatory cell response.
Petrovic D
Folia Biol (Praha); 2004; 50(2):58-62. PubMed ID: 15222127
[TBL] [Abstract][Full Text] [Related]
13. Cardiac remodeling and failure: from molecules to man (Part I).
Fedak PW; Verma S; Weisel RD; Li RK
Cardiovasc Pathol; 2005; 14(1):1-11. PubMed ID: 15710285
[TBL] [Abstract][Full Text] [Related]
14. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
Saccà L; Napoli R; Cittadini A
Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling.
Haider N; Narula N; Narula J
J Card Fail; 2002 Dec; 8(6 Suppl):S512-7. PubMed ID: 12555167
[TBL] [Abstract][Full Text] [Related]
17. Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice.
Tsukamoto O; Minamino T; Okada K; Shintani Y; Takashima S; Kato H; Liao Y; Okazaki H; Asai M; Hirata A; Fujita M; Asano Y; Yamazaki S; Asanuma H; Hori M; Kitakaze M
Biochem Biophys Res Commun; 2006 Feb; 340(4):1125-33. PubMed ID: 16403436
[TBL] [Abstract][Full Text] [Related]
18. Myocyte loss in chronic heart failure.
Rayment NB; Haven AJ; Madden B; Murday A; Trickey R; Shipley M; Davies MJ; Katz DR
J Pathol; 1999 Jun; 188(2):213-9. PubMed ID: 10398167
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide and promotion of cardiac myocyte apoptosis.
Andréka P; Tran T; Webster KA; Bishopric NH
Mol Cell Biochem; 2004 Aug; 263(1-2):35-53. PubMed ID: 15524166
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
